Chile
| Review
APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis
Fecha
2019Registro en:
56, 4, 2450-2465
08937648
Autor
Uddin M.S.
Kabir M.T.
Al Mamun A.
Abdel-Daim M.M.
Barreto G.E.
Ashraf G.M.
Institución
Materias
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Review of the advances in treatment for Alzheimer disease: Strategies for combating β-amyloid protein [Una revisión de los avances en la terapéutica de la enfermedad de Alzheimer: estrategia frente a la proteína β-amiloide]
Folch J.; Ettcheto M.; Petrov D.; Abad S.; Pedrós I.; Marin M.; Olloquequi J.; Camins A. (Spanish Society of Neurology, 2018) -
Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease
Zainaghi, Isis A.; Talib, Leda L.; Diniz, Breno S.; Gattaz, Wagner F.; Forlenza, Orestes V. (SPRINGER WIENWIEN, 2012)Studies have shown that platelet APP ratio (representing the percentage of 120-130 kDa to 110 kDa isoforms of the amyloid precursor protein) is reduced in patients with mild cognitive impairment (MCI) and Alzheimer's disease ...